Basic Information
Basic information for C5orf64-215-13aa-2
Peptide Name C5orf64-215-13aa-2
Genome Position chr5:61706347-61706385[+]
Species Human
Peptide Sequence MKEIVHNISANKQ
Peptide Length 13
Unique No (C5orf64-201-13aa-1,C5orf64-203-13aa-1,C5orf64-210-13aa-2,C5orf64-211-13aa-1,C5orf64-213-13aa-1,C5orf64-225-13aa-2)
Grand Average of Hydropathicity -0.6846
Relative Molecular Mass 1727.94
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000663605;C5orf64-215
Transcript Length 3374
Coding Ability 0.4303
DNA Sequence Corresponding to Peptide ATGAAGGAAATTGTTCACAATATTTCAGCCAATAAACAA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :